Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

14.89$0.45 3.12%
At close       04:00 PM   

Stock Snapshot

14.44
Prev. Close
14.57
Open
1.66B
Market Cap
20.05M
Number of Shares
14.26
Day Low
15.09
Day High
14.89
-
P/E Ratio
105.96M
Free Float in %
-0.10
EPS 2021
0.73
Book Value per Share
3.11
Cash Flow per Share
Dynavax Technologies Corporation (DVAX)
Dynavax Technologies Corporation (DVAX) stock rallied over 3.12% intraday to trade at $14.89 share on NASDAQ. The stock opened with a gain of % at $14.57 and touched an intraday high of $15.09, rising 4.50% against the last close of $14.44. The stock went to a low of $14.26 during the session.

Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-09-17$14.57$14.89$15.09$14.265,932,066
2021-09-16$14.57$14.48$14.71$13.713,667,163
2021-09-15$14.57$13.92$14.71$13.714,779,809
2021-09-14$14.57$14.39$14.71$14.25146,192
2021-09-13$19.12$17.55$19.25$17.414,622,289
2021-09-10$19.12$17.55$19.25$17.414,657,145
2021-09-03$17.07$17.68$18.45$17.00458,590,000
2021-09-02$19.12$17.69$19.19$17.20682,820,000
2021-09-01$20.14$19.00$20.40$18.201,262,250,000
2021-08-31$18.26$19.46$20.00$18.261,014,340,000
2021-08-30$17.44$18.09$18.60$17.10883,270,000
Dynavax Technologies Corporation
2100 Powell Street
Suite 900
EmeryVille, CA 94608
United States

http://www.dynavax.com
510 848 5100
Employees
245
Sector
Healthcare
Sales or Revenue
169.10M
Industry
Biotechnology
5Y Sales Change
63.00
Fiscal Year Ends
2020-12-30

Dynavax Technologies Corporation
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam